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Abstract 
The antidiabetic properties and phytochemical studies of fractions of ethanolic leaf extract (400mg/Kgb.w) of 
Murraya koenigii (M. koenigii) and Telfairia occidentalis (T. occidentalis) was carried out on alloxan induced 
diabetic albino rats. Four and three fractions were obtained from M. koenigii and T. occidentalis extract 
respectively using column chromatography. Phytochemical screening of each fraction, indicate the presence of 
saponins, alkaloids, flavonoids, tannins and cardiac glycosides. The alloxan induced diabetic rats were treated 
with fractions of the extract, and fraction 1 and 2 of M. koenigii and T. occidentalis respectively which decreased 
blood glucose level significantly (p<0.05) by 72% and 78% respectively when compared within the group and 
showed no significant different when compared to normal control group. All treated groups showed no 
significant changes (p<0.05) in their body weight with the exception of groups treated with 3rd fractions of M. 
koenigii and T. occidentalis. Spectroscopic studies indicated the presence of  biological active compound in the 
1st, 2nd and 3rd fractions of M. koenigii that absorbed maximally at 200-350nm and the 4th fraction showed 
absorption maximally at 270nm and 290nm; while the 1st fraction of T. occidentalis absorbed maximally at 
320nm, 2nd fraction at 290nm and 340nm and 3rd fraction at 320nm and 350nm.  The 1st fraction of M. koenigii 
and 2nd fraction of T. occidentalis showed high antidiabetic properties at  λ max 320nm and 340nm respectively. 
Our findings certainly suggest among others the use of plants as a source of  potentially useful antidiabetic 
therapy for diabetics. 
Keywords:  Diabetes mellitus, Antidiabetic components, Telfairia occidentalis and Murraya koenigii 
 
1. Introduction 
One of the biggest challenges to public health globally is diabetes mellitus. Diabetes is a chronic condition 
occasioned by abnormally high level of glucose in the blood. Diabetes mellitus is caused by the abnormality of 
carbohydrate metabolism which is linked to low blood insulin level or insensitivity of target organs to insulin 
(Ahmed et al.,2010). If it is left untreated, it can elicit a number of debilitating consequences such as blindness, 
kidney disease, nerve disease, cardiovascular disease among others. It is a common chronic disease that affects 
over 245 million people worldwide and the number simply keep on growing with each passing day( Prohp and 
Onaogbe,2009; Rahimi,2015). This pattern of prevalence is also experience in Nigeria, were an exponential 
socioeconomic growth over the past few decades has led to a sedentary and affluent lifestyle of the people in the 
urban region (Saxena. et al. 2010). A recent follow up on epidemiological study shows an alarming increase in 
the prevalence of diabetes mellitus during the past few years resulting to public awareness (Al-Daghri et al., 
2011). It has been estimated that by 2030 the figure is expected to double (Wild et al., 2004). 
For many people, diabetes mellitus is a reality that they have to leave with every single day. Diabetes 
kills one person every 10 seconds and infects two persons in the same short time. This is the scary reality behind 
this silent killer which is taking its toll on lives worldwide and even more than HIV/AIDS and Cancer put 
together (Sy et al.,2005) 
Currently available antidiabetic therapies include insulin and various oral antidiabetic agents such as 
sulfonylureas, biguanides and glinides (Patel et al., 2012). As a result of the number of serious adverse effects 
reported for these therapies, there is therefore the need for hypoglycemic agents that will not only be more 
effective but should be relatively safe. Aldol reductases, a key enzyme in the polyol pathway catalyzes the 
reduction of glucose to sorbitol. The accumulation of sorbitol has been shown to cause various complications in 
the body including cataract, neuropathy and nephropathy (Patel et al.,2012). 
 One of the therapeutic options mostly explored is the use natural plant derivatives. Herbal medicines 
from traditional plant have been recommended and are used throughout the world for a range of diabetic 
presentation. 
Murraya koenigii (L.) or its common name curry leaf tree is a small strong smelling perennial shrub 
commonly found in forests as undergrowth. It was originally cultivated in India for its aromatic leaves and for 
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ornament is normally used for natural flavoring in curries and sauces. Originated in Tarai regions of Uttar 
Pradesh, India. It is now widely found in all parts of India and it adorns every house yard of southern India and 
also now cultivated throughout the world including Nigeria. The plant is used in Indian system of medicine to 
treat various ailments (Kumar et al., 1999). Parts of the plant have been used as raw material for the traditional 
medicine formulation in India. This plant is known to be the richest source of carbazole alkaloids (Tachibana et 
al, 2003). It has been reported by authors that carbazole alkaloids present in M.koenigii (L.) and display various 
biological activities such as anti-tumor, anti-oxidative, anti-mutagenic and anti-inflammatory activities (Mandal 
et al.,2010; Muthumani et al., 2010). M. koenigii leaves and roots can be used to cure piles and allay heat of the 
body, thirst, inflammation and itching (Kumar et al.,1999).  
The aromatic leaves, which retains their flavor and other qualities even after drying, are slightly bitter, 
acrid, cooling, weakly acidic in tastes and are considered as a tonic, anthelmintic, analgesic, digestive, appetizing 
and are widely used in Indian cookery for flavoring food stuffs (Adebajo et al., 2004; Mandal et al., 2010). The 
phytoconstituents isolated so far from the leaves are alkaloids viz., mahanine, koenine, koenigine, koenidine, 
girinimbiol, girinimibine, koenimbine, O-methyl murrayamine A, O-methyl mahanine, isomahanine, 
bismahanine, bispyrayafoline and other phytoconstituents such as coumarin glycoside viz., scopotin, 
murrayanine, calcium, phosphorus, iron, thiamine, riboflavin, niacin, vitamin C, carotene and oxalic acid 
(Adebajo et al., 2006; Tachibana et al., 2003 Adebajo and Reisch, 2000). It also reported for anti-microbial, 
antioxidant (Adebajo et al, 2005; Priya et al, 2014). M. koenigii leaves is reported to possess antioxiant, 
antibacterial, antifungal, larvicidal, anticarcinogenic, hypoglycemic, anti-lipid peroxidative, hypolipidemic and 
antihypertensive activity (Ranav et al ,2004; Iyer and Uma, 2008; Rao et al,2011). 
This tropical vine known as Telfairia occidentalis is well grown in West Africa as a leaf vegetable and 
also for its edible seed. It belongs to a member of the Curcurbitaceae family and is indigenous to southern 
Nigeria. Ugu is mostly cultivated in Nigeria by the south eastern Nigeria, and widely distributed among the Igbo 
speaking people, particularly Imo state. It is mainly used in soups and herbal medicines (Oyekunle and 
Oyerele,2012) . The seed produced by the gourd are high in protein and fat, and can therefore contribute to a 
well-balanced diet. It is widely cultivated in the West and Central Africa (Benin Republic, Cameroon, Nigeria, 
Sierra Leone to Angola, and up to Uganda in east Africa). It is called ‘ugu’ by the Igbos, ‘ugwu’ by the Yorubas 
and ‘ekobon’ by the Cameroonians (Francis,2015). The various extracts of Telfairia occidentalis leaves reported 
to be anticancer, antioxidant (okokon et al., 2012), anti-HIV reverse transcriptase (Dowluru et al,2015), 
hepatoprotective (Oboh,2005;Dowluru et al,2015) , anti in-flammatory (Okokon et al., 2012) , anti-hepatitis 
(Rupam et al.,2012) and aphrodisiac. It has also been reportedly used in the management of 
hyperchelsterolaemia, liver problems, and impaired immune system (Usman et al.,2015), remedy reproductive 
and fertility issues (Oboh,2005),treatment of malaria as well replenish lost blood due to its high iron content 
among others 
To curtail this metabolic disorder and its implication, many synthetic therapeutic agents has been 
introduce with minimal significant success, giving raise for a search of a better drug. In recent years, 
ethnobotanical and traditional uses of natural compounds, especially of plant origin received much attention as 
they are well tested for their efficacy and generally believed to be safe for human use. This quest has led to the 
employment of plants for the management of diabetes mellitus. A review of the medicinal plants used in Nigeria 
for the treatment of diabetes mellitus indicates that a rich flora diversity exist in Nigeria. They obviously deserve 
scrutiny on modern scientific lines such as phytochemical investigation, biological evaluation on experimental 
animal models, toxicity studies, isolation of active components, investigation of molecular mechanism of action 
s of isolated phyto-principles and their clinical trials (Audu, 1989 and Harish et al., 2012). 
With the prevalence increase in diabetes mellitus in Nigeria and it subsequent management, its effect on 
human socio-economic and its challenges worldwide in term of therapeutic management, therefore the need to 
search for drug that is cheaper, safer and available from plants products. With respect to search for drug that is 
cheaper, safer and available from plants products; Iliyasu (2013) and Endas (2014) investigated the antidiabetic 
properties of Murraya koenigii and Telfairia occidentalis, and reported that these plants posses’ antidiabetic 
properties but their work did not specify the antidiabetic components nor its mechanism of action.  
It is in the light of this background that the present was initiated to investigate the antidiabetic 
properties and phytochemical studies of fractions of ethanolic leaf extract  of Murraya koenigii (M. koenigii) and 
Telfairia occidentalis (T. occidentalis) on alloxan induced diabetic albino rats. 
 
2 Materials and Methods 
2.1 Materials 
2.1.1 Sample Collection and Processing 
The fresh leaves of the plants Telfairia occidentalis and Murraya koenigii were  purchased from traditional herb 
dealers in  Kaduna central Market, Kaduna State of Nigeria.  The plants were further authenticated in the Botany 
unit, Department of biological science, Kaduna State University. 
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2.2  Chemicals 
Alloxan monohydrate, silica gel and meyer’s reagent were supplied by Sigma –Aldrich Co. USA. Ethanol, 
dimethyl sulphoxide, chloroform, concentrated sulphuric acid and ammonia solution were supplied by British 
Drug House (BDH) chemicals, Poole, England . Sodium dihydrogen phosphate, disodium hydrogen phosphate, 
ferric chloride, glacial acetic acid were products of  Pharmacia Fine Chemicals, Upsala, Sweden. All other 
chemicals and reagents used for the study were of analytical grade and supplied by reputable chemical 
manufacturers. 
 
2.3 Sample preparation  
 The samples were prepared according to the method described by by Gohil et al., (2010). In this method, fresh 
leaves of the plants Telfairia occidentalis and Murraya koenigii were washed and dried at room temperature and 
were pounded into smooth powder. 100gm of each the pounded leave powder was soaked in 400ml of 70% 
ethanol and were allowed to stand for 24hrs. After 24hrs, the mixtures were filtered through several folded clean 
muslin cloth to remove debris, the filtrates collected through muslin cloth were re-filter through cotton wool and 
through 2-folded Whatman filter paper. The volumes of the filtrates were taken and were evaporated to dryness 
using rotary evaporator (NCY model R-205D. The weight of the extracts was taken and the extracts were 
transferred to plastic containers and store in the refrigerator for the next step.  
 
2.4 Preparation of chromatography column (Silica gel). 
The column was washed and rinsed with deionized water, a plastic funnel was placed on top of the column 
which serves as the packing and buffer reservoir. The chromatography column was filled to about one third with 
phosphate buffer (pH 6.30). 
 In a beaker 160ml (103g) of silica gel was measured out, in a separate beaker 350ml of phosphate 
buffer was measured and used to dissolve the silica gel to form slurry. The prepared slurry was poured into the 
column while allowing the tap open to prevent overflow. The column was shake for 2mins to ensure proper 
packing. The excess buffer in the column was removed and  the gel ready for use according to standard 
procedure. 
 
2.5 Fractionation of plant’s crude extracts. 
The ethanolic plant extracts of Telfairia occidentalis and Murraya koenigii were reconstituted with 30ml of 
phosphate buffer (pH 6.30) followed by addition of 5ml of dimethyl sulphoxide to aid in the solubility of the 
plant extracts. The reconstituted solution of the plant extract was loaded into the prepared column above and was 
allowed to move through the inlet to outlet of the column and collection of different fractions base on the number 
of layers formed on the column, the retention time, volume and concentration in mg/ml of each fraction was 
noted. Each of the fraction collected was used to administered orally to a particular group of induce diabetes rats 
for the period of the experiment.  
 
2.6 Experimental animals 
Albino rats of both sexes weighing between 70-230g were obtained from National Vertinary Research Institute 
(NVRI) Vom, plateau state was used. The animals were allowed to have free access to food and water under well 
ventilated conditions daily. Grower’s mash and tap water were used to feed the animals throughout the 
experimental period. 
 
2.7 Weighing of animals/grouping 
The rats were weighed using top loading weighing balance (Jenway, Model KL 191-200g/0.01). A suitable 
container was placed on the weighing balance and the machine was zero. The rats were placed one after the other 
from each group and their weighs were noted. 
The animals were grouped into nine groups and label accordingly. Each group contains four rats. The  
groups were as follows: TL1,TL2 and TL3  were treated with 1st,2nd and 3rd  fractions of Telfairia occidentalis 
respectively,  ML1,ML2 ML3 and ML4 were treated with 1st, 2nd, 3rd and 4th  fractions of Murraya koenigii 
collected from the earlier fractionation.  
 
2.8 Induction of diabetes 
The rats in ML1, ML2, ML3, ML4, TL1, TL2, TL3 and DC groups were made to fast for 12 hrs before the 
induction of diabetes. Thereafter they rats were injected intraperitonealy with freshly prepared alloxan 
monohydrate (150mg/kg body weight). Two days after injection, the blood glucose of the rats was determined 
using ON-CALL glucometer (AVC model), the rats with fasting blood glucose higher than 6.2mmol/L were 
considered diabetic and used for the experiment. Feeding was stopped 12 hrs before blood sampling was taken. 
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2.9  Blood glucose level estimation 
Fasting blood glucose was determined using the strip of digital ON-CALL glucose meter (AVC model). A drop 
of blood was obtained from the tip of conscious rat’s tail and placed on the strip. The reading on the meter was 
noted and recorded as the blood glucose concentration. The ON-CALL glucometer strip uses glucose the 
chemistry of dehydrogenase. The glucose dehydrogenase in the strip converts the glucose in the blood sample to 
gluconolacton and through series of reaction a small current is generated that is read by the meter as glucose 
level. 
 
2.10 Phytochemical screening 
Phytochemical screening test was carried out on each fractions of the plants extract Telfairia occendentalis and 
Murraya koenigii. 
2.10.1 Test for flavonoids 
This was determined according to the method described by Ayoola et al., (2008). In this method, 2ml of aqueous 
plants extract was taken together with 5ml of dilute ammonia followed by addition of 1ml concentrated sulphuric 
acid. A yellow colouration that disappears on standing indicates the presence of flavonoids. 
2.10.2 Test for saponins 
This was determined according to the method described by Sofowora (1993). In this method, 5ml of the plants 
extract fraction was dispensed into a test tube and agitated vigorously till a persistent froth is observed followed 
by further addition of  3 drops of olive oil. Formation of emulsion on agitation indicate  the  presence of saponins. 
2.10.3 Test for tannins 
This was determined according to the method described by Ayoola et al., (2008). In this method, about 5ml 
aliquot of the plant extract   was boiled in a test tube and then filtered. A few drops of 0.1% ferric chloride was 
added and observed.  Brownish green or a blue-black colouration indicate the presence of tannins. 
2.10.4 Test for alkaloids 
This was determined according to the method described by Trease and Evans (1989), in this method, 5ml aliquot 
of plant extract was diluted to 10 ml with acidified alcohol which was boiled and filtered. To 5 ml portion of the 
filtrate, 2 ml of dilute ammonia was added, together with 5ml of chloroform and the reaction mixture shaken 
gently to extract the alkaloidal base. The chloroform layer was extracted with 10 ml of acetic acid. Mayer’s 
reagent was added to the extracted portion. The formation of a cream colour indicates positive result for the 
presence of alkaloids.  
2.10.5 Test for glycosides (Keller-Killiani test) 
This was determined using the Keller-Killiami’s test as  described by Trease  and Evans (1989), in this method, 
5ml  of plant’s extract fraction was taken into a test tube with 2 ml of glacial acetic acidin which one drop of 
ferric chloride solution was added and the reaction mixture  under laid with 1 ml of concentrated sulphuric acid. 
A brown ring at the interface indicated the presence of a deoxysugar characteristic of cardenolides. 
   
2.11 Spectroscopy studies of the plant’s extracts fraction  
Each fraction of the plant’s extracts was subjected to spectroscopy studies at different wavelength according to 
standard procedure. The absorbance of each of the fraction was measured at wavelength range of 200-700nm at 
the interval of 5nm. The absorbance obtained was used to plot the spectrum of each fraction so as  to determine 
the λmax of each fraction from the spectra. 
 
2.12 Statistical analysis 
Results were expressed as mean ± S.D.  Data were analyzed with t - test for comparison between the groups. The 
significance level was set at P<0.05. 
 
3.0 Results 
In our study we report the result of the antidiabetic properties and phytochemical studies of fractions of ethanolic 
leaf extract (400mg/Kgb.w) of Murraya koenigii (M. koenigii) and Telfairia occidentalis (T. occidentalis)   that 
was carried out on alloxan induced diabetic albino rats  for  a period of fourteen days.  
The yield of the ethanolic leaf extracts obtained from 100g of Telfairia occidentalis and Murraya 
koenigii was 5.1g and 5.5g respectively. 
Four and three fractions were obtained from M.koenigii and T. occidentalis extract respectively (see 
table 1) Phytochemical screening of each fraction, indicate the presence of saponins, alkaloids, flavonoids, 
tannins and cardiac glycosides (see table 2.) 
Throughout the experiment period there was follow up sleep in all the rats in the treated groups 
immediately after oral administration of the fractions of the plant extracts which suggested that the plants  under 
study possesess sedative properties. Moreso, two rats in both ML3 and ML4 treated groups developed ulcer after 
five days of treatment which disappeared after twelve days of treatment.  
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Table 1: Retention time, volume and concentration of various fractions obtained from column chromatography 
process of ethanolic leaf extracts of Telfairia occidentalis and Murraya koenigii 
         Fractions Retention time 
(min) 
Volume (ml) Concentration of bioactive component 
(mg/ml) 
ML1 9.5 40.0 42.0 
ML2 12.5 43.0 39.0 
ML3 14.0 96.5 26.0 
ML4 16.5 120.5 24.0 
TL1 8.5 42.5 34.0 
TL2 12.5 47.5 28.0 
TL3 13.9 47.0 24.0 
The ML1, ML2, ML3 and ML4 represent 1st, 2nd , 3rd and 4th fraction of M. koenigii respectively while 
TL1, TL2 and TL3 represent  1st, 2nd and 3rd fraction of T. occidentalis respectively. The fraction was obtained 
from column chromatography packed with silica gel size (8cmx500mm). Retention time is the time taken for the 
plants extract solution to move from the inlet of the column, separate and come out of the column as eluent.   
The alloxan induced diabetic rats were treated with fractions of the extract, and ML1 and TL2 fraction 
decreased blood glucose level significantly (p<0.05) by 72% and 78% respectively when compared within the 
group but showed no significant difference when compared to normal control group at the end of the experiment. 
However rats in groups treated with ML2, ML3, ML4, TL1 and TL3 fraction showed no significant decreased in 
blood glucose level. (see table 3). Diabetic control group rats showed no significant increase (p<0.05) in blood 
glucose level at the end of the experiment while normal control group also showed no significant difference 
(p<0.05) in blood glucose level. Moreso, all rats in both treated groups and control groups showed no significant 
changes (p<0.05) in their body weight with the exception of groups treated with ML3 and TL3 (see table 3). 
Table 2: Phytochemical screening on fractions of ethanolic extacts of Telfairia occidentalis and Murraya 
koenigii. 
Fractions Saponins Flavonoid  Tannins Alkaloids Glycosides 
 
ML1 
 
  - 
 
  - 
 
  + 
 
+++ 
 
  - 
 
ML2 
 
 +++ 
 
  +++ 
 
 ++ 
 
 + 
 
  - 
 
ML3 
 
++ 
 
 ++ 
 
   - 
 
 - 
 
 + 
 
ML4 
 
  - 
 
 + 
 
 - 
 
 - 
 
 - 
 
TL1 
 
  - 
 
  + 
 
- 
 
 + 
 
 - 
 
TL2 
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 - 
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TL3 
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The + sign indicate the presence of  the molecule while (-) sign indicate absence of the molecules in the 
fraction, triple, double and single plus sign (+) indicate presence of molecules in high, moderate and low 
concentration respectively. 
Table 3: The effect of fractions of ethanolic leaf extracts of Telfairia occidentalis and Murraya koenigii on body 
weight on alloxan induced diabetic albino Wister rats 
Group Initial weight  
±SD 
(g) 
Body weight after induction and commencement of 
treatment of diabetes (g) 
1st Day 14th Day 
ML1 133.5+17.20 132.11+12.55 139.73+11.5 
ML2 123.66+15.22 119.01+0.88 131.94+3.66 
ML3 69.27+14.90A 71.97+14.04* 100.99+17.0* 
ML4 139.14+16.51 140.04+13.77 131.62+21.42 
TL1 169.68+11.65 166.92+11.62 152.67+29.56 
TL2 142.36+2.59 143.89+3.96 149.42+19.48 
TL3 68.92+13.35 A 70.95+10.86 83.58+13.19* 
DC 137.66+12.66 141.74+12.97 134.72+14.85 
NC 135.24+41.06 135.33+41.17 139.85+35.78 
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Values are given as mean ± standard deviation (SD), (n=4); Values followed by different letters are 
significantly different at p<0.05 between the groups and those followed by different number of asterisk   are 
significantly different within the groups at p<0.05. Unpaired sample student t-test was used for comparing 
between the groups, while paired sample t-test was used to compare within the groups. 
The fractions of both extracts were scanned using UV-spectrophotometer (Model: UV 752) at 
wavelength between 200-700nm wavelengths at interval of 5nm. The fractions TL1, TL2, TL3 and ML4 gave 
spectra with heterogeneous peaks which absorbed maximally at wavelength between 200-350nm (see figure 1 
and 2). The following absorptions were observed: ML1 fraction, 320nm ( being the λmax of the fraction);  ML2 
fraction,  390nm (minor Peak) and 350nm  (major peak and being the λmax of the fraction); ML3 fraction, 350nm 
(minor peak) and  320nm ( major peak and being the λmax  of the fraction);  ML4 fraction, 270nm (minor peak) 
and 290nm (major peak and being the λmax of the fraction); TL1 fraction 340nm (being the λmax of the fraction); 
TL2 fraction, 310nm (minor peak) and 340nm ((major peak and being the λmax of the fraction) and TL3 fraction, 
300nm (minor peak) and 320nm (major peak and being the λmax of the fraction see figure 1 and 2).   
Table 4: The effect of fractions of ethanolic leaf extracts of Telfairia occidentalis and Murraya koenigii, on 
blood glucose levels on alloxan induced diabetic albino Wister rats     
Group Initial blood glucose 
(mmol/L) 
Blood glucose level after induction and commencement of 
treatment of diabetes (mmol/L) 
  1st Day 7th Day 14th Day 
ML1 4.39+1.12 20.93+10.12 B* 16.47+10.22 B* 5.73+1.49A** 
ML2 4.02+0.71 7.70+1.47* 7.20+1.57B* 6.75+1.48B* 
ML3 4.45+0.64 10.93+4.60 B* 8.67+5.81 B* 7.85+4.29* 
ML4 3.48+0.62 B 9.87+5.47* 6.75+1.61* 6.50+1.15B* 
TL1 4.38+0.92 16.82+13.37 B* 19.17+10.88 B* 13.63+6.89 B* 
TL2 4.30+10.09 20.88+10.32B* 5.03+0.81A** 4.55+0.90 A** 
TL3 3.70+0.78 9.05+1.26* 7.00+1.26* 7.05+1.58 B* 
DC 3.48+1.01 11.02+4.66 B * 12.18+5.82 B* 12.15+5.57A B * 
NC 4.98+0.98 A 4.90+1.19 A 5.95+0.93A 5.13+0.39 A 
Values are given as mean ± standard deviation (SD), (n=4); Values followed by different capital letters 
are no significantly different at p<0.05 between the groups and those followed by different number of asterisk   
are significantly different within the groups at p<0.05. Unpaired sample student t-test was used for comparing 
between the groups, while paired sample t-test was used to compare within the groups.  
 
Figure 1: The spectrum of four fractions of ethanolic leaf extract of M. koenigii. [The blue, red, green and purple 
line represent the 1st, 2nd, 3rd and 4th fraction] 
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Figure 2: The spectrum of four fractions of ethanolic leaf extract of T. occidentalis. [The blue, red, green and 
purple line represent the 1st, 2nd and 3rd fraction]. 
 
4 Discussion 
One of the ultimate goal of diabetes research and management is the prevention of long-term complication; 
where agents under study for either remedy or abating is aimed at improving and maintaining the glycemic 
control over time. Peyrot et al (2005) noted that these goals cannot come so easy as the progressive nature of the 
disease affects optimization time of treatment leading in a majority of cases being observed with the available 
drugs.  
In the present study the antidiabetic properties of the fraction of ethanolic extracts of Telfairia 
occidentalis and Murraya koenigii was investigated in alloxan induced diabetes rats. The phytochemical 
screening of the fractions revealed some differences in the constituents of the phytochemical components in each 
of the fraction which indicated that plants under study contain phytochemical components that are of different 
molecular weight since fractionation of the extract was obtained via size exclusion chromatography, suggesting 
that each fraction may have different therapeutic effects.  
The significant decrease in blood glucose observed in the groups treated with these fractions ML1 and 
TL2 was an indication of presence of antidiabetic components. The hypoglycemic effect observed in ML1 and 
TL2 treated groups may be due to action of the flavonoid, saponins, alkaloid and tannins present in the fractions 
since diabetic control group rats showed no significant decrease in blood glucose level. Although other fractions 
(ML2, ML3, ML4, TL1 and TL3) phytochemical screening results indicated the presence of flavonoids, 
alkaloids, tannins and saponins as ML1& TL2 indicated, but no significant decrease (p<0.05)  in blood glucose 
was observed in groups treated with ML2, ML3, ML4, TL1 and TL3 fraction, this indicated that; the alkaloids, 
saponins, and tannins present in ML1 & TL2 fraction are structurally and functionally different from the one 
contained in ML2, ML3, ML4, TL1 and TL3 fractions. The flavonoids, alkaloids, saponins and tannins may have 
scavenged all the free radicals that were introduced into the beta-cells by the alloxan which led to the quick 
regeneration of beta-cells and ultimately improved  insulin secretion or they may have inhibit the activity of the 
alpha amylases making carbohydrate food biologically unavailable ( Harish et al., 2012 and Dineshkumar et al., 
2010).  
Lass’a (1991) noted that every organism has a growing stage, and when the organism is out of growing 
stage, the increase in weight within a short period of time is not always significant. Findings from present study 
( shown in table 3) suggest that the significant increase in weight observed in ML3 and TL3 was not a function 
of components present in the fraction and does not depend on the blood glucose level. Hence, the gain in weight 
by the rats is as a result of the growing stage they were able to utilize the available nutrients in building up their 
bodies; while others treated group showed no significant increase which may be possibly attributed to the fact 
that  they were out of their growing stage. Moreover, weight loss is known to be associated with diabetes 
mellitus due to inability of the body’s cells to utilized glucose for energy production resulting to constant hunger 
( Cortran et al., 1999).  These combine effect has the  potential of  influencing a rapid weight loss as a result of 
constant hydrolysis of protein and store fats for energy production leading to the body weight loss being 
observed (Verdich et al., 2001).  
Spectra of the fractions showed peaks at different wavelength which suggest that the fractions contain 
difference components. The ML1 and TL2 fraction which showed high antidiabetic properties have λmax 320nm 
and 340nm respectively, suggesting that ML1 fraction may contain alkaloid such as Mahanimbine (λmax= 326nm),  
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murrayanol  (λmax= 330nm), Hydrolysable tannins such as chibulagic acid  (λmax= 276nm), Altagic acid  (λmax= 
253nm), ethyl gallate  (λmax= 271nm) and cardiac glycoside  (λmax= 253nm); while TL2 fraction may contain 
Mahanine alkaloids (λmax= 340nm), berberine alkaloid (λmax = 342nm), Saponins (λmax= 350nm) (), and 
Hispidulin flavonoids (λmax= 338nm) ((Pfoze et al., 2014; Anil et al., 2013; Hediat et al,. 2012; Mahajan and 
Pai.,2010 and Knolker and Peddy, 2002). The λmax of ML1 TL2 fraction are great agreement with λmax of 
Murrayanol alkaloids and Mahanine alkaloids respectively.  
 
5 Conclusion  
The present study has demonstrated that ethanolic extracts of Telfairia occidentalis and Murraya koenigii 
possess antidiabetic activity. Further spectroscopic studies have shown that the observed components responsible 
for the antidiabetic properties of the plants Telfairia occidentalis and Murraya koenigii absorbed UV-light 
maximally at 340nm and 320nm respectively. This strongly suggest that the antidiabetic components of these 
plants (Telfairia occidentalis and Murraya koenigii)  may have structural similarity with Mahanine alkaloids and 
Murrayanol alkaloids respectively. At present, the treatment of diabetes mainly involves a sustained reduction in 
hyperglycemia by the use of orthodox therapy and α-glucosidase inhibitors in addition to insulin. However, due 
to unwanted side effects, the efficacies of these compounds are contestible thus fuelling the potential for 
alternative therapy in the treatment of diabetes (Oubre et al.,1997; Fabricant and Farnsworth,2001;). It is for this 
reason   that plants have been suggested as a rich, but largely unexplored source of potentially useful antidiabetic 
therapy. Furthermore, only a few have been subjected to detailed scientific investigation due to a lack of 
mechanism-based available in vitro assays procedures (Habeck,2003 and Rahimi, 2015). Nonetheless our modest 
effort is another addition to the library of data and further justification for the novel role of   traditional plants in 
the treatment of diabetes mellitus. 
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